DR. MRS. RENUKA DATLA versus SOLVAY PHARMACEUTICAL B.V. AND ORS.

DR. MRS. RENUKA DATLA versus SOLVAY PHARMACEUTICAL B.V. AND ORS.

In the absence of any specific and clear provision in the settlement regarding control premium or method, Court cannot superimpose such terms; valuation not vitiated by any demonstrably wrong approach or fundamental error, and the valuer correctly excluded brands not recorded as assets. Discounted cash flow method was not obligatory as relevant projections differed substantially and past earnings method was adequate.

Parties
Petitioner: Dr. Mrs. Renuka Datla; Petitioner: Dr. Vijay Kumar Datla; Respondent: Solvay Pharmaceutical B.V.; Respondent: Shri D. Vasant Kumar
Jurisdiction
India
Judgment Date
30 October 2003
Procedural Posture
Special Leave Petition / Final Disposition After Settlement and Valuation Challenge
Outcome
Special Leave Petitions disposed of in terms of settlement with direction regarding interest
Legal Topics
Valuation of Shares, Transfer of Share Holdings, Judicial Intervention in Valuation, Settlement of Corporate Disputes
Company Law Valuation of Shares Transfer of Share Holdings Judicial Intervention in Valuation Settlement of Corporate Disputes

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Legal principles 2 Authorities cited 6 Party arguments 2 Amounts and remedies 3
Sign in to unlock

Parties

Dr. Mrs. Renuka Datla

Petitioner

Dr. Vijay Kumar Datla

Petitioner

Solvay Pharmaceutical B.V.

Respondent

Shri D. Vasant Kumar

Respondent

Procedural Posture

Special Leave Petition / Final Disposition After Settlement and Valuation Challenge

Legal Issues

  1. 1 Whether judicial intervention in valuation is permissible despite settlement
  2. 2 Whether omission of control premium and excluded brand values vitiates share valuation
  3. 3 Whether discounted cash flow method should have been applied in valuation

Ratio Decidendi

In the absence of any specific and clear provision in the settlement regarding control premium or method, Court cannot superimpose such terms; valuation not vitiated by any demonstrably wrong approach or fundamental error, and the valuer correctly excluded brands not recorded as assets. Discounted cash flow method was not obligatory as relevant projections differed substantially and past earnings method was adequate.

Court Disposition

Special Leave Petitions disposed of in terms of settlement with direction regarding interest

Orders

  • Respondents to pay the sum of Rs. 8.24 crores representing the value of 4.91% shares together with interest @ 9% for a period of 12 months within four weeks from the order, subject to receipt of share transfer forms and fulfilment of other formalities.
  • Suits and proceedings underlying these SLPs and mentioned in the settlement memorandum shall stand dismissed as withdrawn.